PV Bulletin

End of Windows 10 Support and Its Impact on Medical Devices

Some medical devices may be affected by the end of support for Microsoft Windows 10, raising cybersecurity concerns.

Primary source: Safety monitoring and information

PV Impact Brief

Urgency: HighConfidence: high

What changed

Manufacturers and sponsors are now required to develop a transition timeline to ensure continued security and compliance, including notifying customers if hardware upgrades for Windows 11 are needed.

Why it matters

The end of support could expose devices to cyber incidents, jeopardizing patient data and device functionality, thus necessitating immediate action from manufacturers to safeguard users.

Action needed

Companies must implement a strategy to upgrade from Windows 10 to Windows 11 and ensure compliance with essential safety principles, including notifying customers about potential vulnerabilities.

Relevant for
Medical Safety Lead
Processes impacted
Signal ManagementVendor Oversight
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 17, 2026

Full briefing

Practical implication

Companies must implement a strategy to upgrade from Windows 10 to Windows 11 and ensure compliance with essential safety principles, including notifying customers about potential vulnerabilities.

With the cessation of support for Microsoft Windows 10 on October 14, 2025, devices that have not upgraded to Windows 11 may face increased cybersecurity risks and lack of support, necessitating a transition plan for manufacturers.

What changed: Manufacturers and sponsors are now required to develop a transition timeline to ensure continued security and compliance, including notifying customers if hardware upgrades for Windows 11 are needed.

Why it matters: The end of support could expose devices to cyber incidents, jeopardizing patient data and device functionality, thus necessitating immediate action from manufacturers to safeguard users.

Practical implication: Companies must implement a strategy to upgrade from Windows 10 to Windows 11 and ensure compliance with essential safety principles, including notifying customers about potential vulnerabilities.

View original source

  • Source: TGA Safety Alerts - News feed
  • Published at source: 2026-08-17T22:18:00.000Z
  • Discovered by monitor: 2026-08-17T22:20:48.220Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signals#Device Vigilance#Australia#Source-ingestion#Regulator-monitor#Tga.gov.au

Related updates for your role

publicMedicines and Healthcare products Regulatory Agency (MHRA) · United Kingdom · Updated Aug 18, 2026

UK Position Paper on Microbiome-Based Medicinal Products (MBMPs)

Urgency: High

MAHs and sponsors must enhance their pharmacovigilance systems to monitor microbiome-specific safety issues, comply with established safety standards, and address concerns related to antimicrobial resistance.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Position Paper
Read impact briefarrow_forward
publicU.S. Food and Drug Administration · United States · Updated Aug 18, 2026

Regulatory Framework for Generative AI-Enabled Medical Devices

Urgency: High

Stakeholders, including manufacturers and clinicians, must review and potentially revise their post-market vigilance and safety monitoring protocols in response to the FDA's proposed regulatory approaches for generative AI devices.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicFDA · United States · Updated Aug 19, 2026

Guidance on Developing Cellular and Gene Therapy Products

Urgency: High

Clinical safety and pharmacovigilance teams should review the FDA guidance and adjust their monitoring plans to ensure they align with the newly provided recommendations regarding safety endpoints and data collection processes.

Signal ManagementLiterature SurveillanceRegulatory Intelligence Lead
SOP Impact3 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Guidance
Read impact briefarrow_forward
publicTherapeutic Goods Administration (TGA) · Australia · Updated Aug 19, 2026

Enforcement action disrupts illicit vape distribution network in Sydney

Urgency: High

Ongoing investigations into unlawful vaping products are expected to result in further enforcement actions, including additional seizures and potential penalties for non-compliance with the Therapeutic Goods Act.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward